Staccato Zaleplon Single Dose Pharmacokinetics
| Status: | Completed |
|---|---|
| Conditions: | Healthy Studies |
| Therapuetic Areas: | Other |
| Healthy: | No |
| Age Range: | 18 - 55 |
| Updated: | 3/15/2017 |
| Start Date: | February 2008 |
| End Date: | March 2008 |
Safety, Tolerability, and Pharmacokinetics of a Single Dose of Staccato® Zaleplon for Inhalation in Healthy Volunteers
The purpose of the study is to determine the safety, tolerability and pharmacokinetics of
zaleplon delivered by the Staccato thermal aerosol system in healthy volunteers
zaleplon delivered by the Staccato thermal aerosol system in healthy volunteers
Inclusion Criteria:
- Male and female subjects between the ages of 18 to 55 years, inclusive who are in
good general health
Exclusion Criteria:
- Subjects with a history of allergy or intolerance to zaleplon. Subjects who have any
other disease or condition, by history, physical examination, or laboratory
abnormalities that in the investigator's opinion, would present undue risk to the
subject, or may confound the interpretation of study results.
We found this trial at
1
site
Click here to add this to my saved trials
